What is the evidence for stopping long-acting beta2-agonists for adults with stable asthma using combination therapy? | Cochrane

Stopping long-acting beta2-agonists (LABA) for adults whose asthma is stable with LABA and inhaled corticosteroid (ICS) treatment may increase the number of asthma attacks that require treatment with extra corticosteroids, but this remains uncertain. Stopping LABA may also slightly reduce quality...